AMD Stock Surges Above Buy Point; Chipotle Boasts Rising Profit Estimates| Investor's Business Daily | Old North State Wealth News
Connect with us

Economy

AMD Stock Surges Above Buy Point; Chipotle Boasts Rising Profit Estimates| Investor’s Business Daily

Published

on

Advanced Micro Devices (AMD) and Chipotle Mexican Grill (CMG) made Wednesday’s IBD Screen Of The Day, a column that focuses on top ideas in the IBD Stock Screener.




X



Wednesday’s stocks to watch come from the “Rising Profit Estimates” screen, which finds issues attracting higher price targets and analyst upgrades. In addition to AMD and CMG, the latest screen has also flagged Fox Factory (FOXF) and Insulet (PODD).

AMD Stock Tops Buy Point

AMD stock broke out past a flat base’s 89.04 buy point on Wednesday, according to IBD MarketSmith chart analysis. Shares surged 7.7% Thursday, moving out of buy range past the entry. Bullishly, the relative strength line is at its highest level since August. However, the stock market correction means investors should avoid stock buys until the market improves.

Advanced Micro posted a 25% year-over-year earnings drop to 69 cents per share last quarter. In the prior three periods, it reported 117%  and 67% earnings growth, followed by an 8% decline. Look for a return to earnings growth for the current quarter.

Revenue growth has stayed positive for the chipmaker. Sales last quarter grew 16% to $5.59 billion, smaller than the 71%, 70% and 29% upticks in the prior three quarters.

For 2023, AMD earnings are expected to fall 11% before jumping 39% in 2024.

Amid solid fundamentals and big price gains in recent months, AMD stock boasts a strong 95 out of 99 IBD Composite Rating, according to IBD Stock Checkup.

Chipotle Back Above Key Level

This week, Chipotle stock moved further above its key 50-day moving average. Shares are climbing the right side of a flat base that offers a 1,724.81 buy point.

CMG stock moved up 2.15% Thursday, about 6% away from the latest buy point.

The burrito chain missed fourth-quarter earnings, revenue and same-store sales estimates on Feb. 7. Despite the miss, earnings and sales rose 49% and 11%, respectively, vs. the year-ago period.

Chipotle’s earnings are expected to grow 28% in 2023 and 22% in 2024.

Fox Factory, Insulet Eye Buy Points

Similar to AMD stock, Fox Factory is tracing a flat base, this one with a 127.64 buy point, as shares rebound from their 50-day line during Thursday’s 0.6% climb.

With 20 locations across four continents, Fox Factory makes high-performance suspension products used on bicycles, on-road vehicles, all-terrain vehicles (ATVs), snowmobiles, commercial trucks and specialty vehicles.

Insulet jumped this week on news that it will join the S&P 500, replacing SVB Financial (SIVB). Shares are nearing a consolidation’s 320.10 buy point and are 4% away from the entry.

The company sells insulin pumps for genetic type 1 diabetes and the progressive type 2 condition. Diabetes patients need additional insulin to keep their blood sugar in check.

Insulet’s devices are body-worn insulin delivery systems. The company recently launched a new device for type 1 patients age 2 and up, dubbed Omnipod 5.

YOU MAY ALSO LIKE:

Top Growth Stocks To Buy And Watch

Learn How To Time The Market With IBD’s ETF Market Strategy

Find The Best Long-Term Investments With IBD Long-Term Leaders

MarketSmith: Research, Charts, Data And Coaching All In One Place

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks

Dow Jones Futures Fall Ahead Of Jobless Claims; First Republic Plunges 25% on Possible Sale

Read the full article here

Trending

Copyright © 2022 ONSWM News. Content posted on the Old North State Wealth News page was developed and produced by a third party news aggregation service. Old North State Wealth Management is not affiliated with the news aggregation service. The information presented is believed to be current. It should not be viewed as personalized investment advice. All expressions of opinion reflect the judgment of the authors on the date the articles were published. The information presented is not an offer to buy or sell, or a solicitation of any offer to buy or sell, any of the securities discussed.